ViaLase

ViaLase, Inc. is a globally-minded, venture and strategic capital-backed, clinical stage medical technology company headquartered in Aliso Viejo, California, founded and led by Tibor Juhasz, PhD. The company develops the ViaLuxe Laser System, which combines femtosecond laser technology with micron-resolution OCT image guidance to perform femtosecond laser image-guided high-precision trabeculotomy (FLigHT) — a noninvasive, non-incisional procedure that creates drainage apertures through the trabecular meshwork to lower intraocular pressure in patients with open-angle glaucoma. The system pairs the ViaLuxe laser with the ViaLens patient interface and the ViaVue gonio camera. The company closed an approximately $40 million Series C financing in April 2024 with participation from Venture Investors Health Fund, Arboretum Ventures and Falcon Vision. The ViaLase Laser received CE Mark approval in the European Union in 2024 for adult patients with primary open-angle glaucoma and is under evaluation in a US IDE clinical trial; it is not approved for sale in the United States. ViaLase is a medical device manufacturer rather than a software vendor: it publishes no public API, developer portal, SDK, or machine-readable specification, and vialase.com is a WordPress marketing and clinical-education site.

ViaLase is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, MedTech, and Ophthalmology.

ViaLase’s developer surface includes engineering blog and 6 more developer resources.

6.7/100 minimal Agent 0/100 human only Full breakdown ↓
scored 2026-09-02 · rubric v0.18.0
0 APIs
CompanyMedical DevicesHealthcareMedTechOphthalmologyGlaucomaFemtosecond LaserSurgical DevicesClinical TrialsMedical Imaging

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-02 · rubric v0.18.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/vialase: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Vialase Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Commercial 1

Pricing, plans, and the legal terms of use

Company 4

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: vialase
name: ViaLase
description: 'ViaLase, Inc. is a globally-minded, venture and strategic capital-backed, clinical stage medical technology
  company headquartered in Aliso Viejo, California, founded and led by Tibor Juhasz, PhD. The company develops the ViaLuxe
  Laser System, which combines femtosecond laser technology with micron-resolution OCT image guidance to perform femtosecond
  laser image-guided high-precision trabeculotomy (FLigHT) — a noninvasive, non-incisional procedure that creates drainage
  apertures through the trabecular meshwork to lower intraocular pressure in patients with open-angle glaucoma. The system
  pairs the ViaLuxe laser with the ViaLens patient interface and the ViaVue gonio camera. The company closed an approximately
  $40 million Series C financing in April 2024 with participation from Venture Investors Health Fund, Arboretum Ventures and
  Falcon Vision. The ViaLase Laser received CE Mark approval in the European Union in 2024 for adult patients with primary
  open-angle glaucoma and is under evaluation in a US IDE clinical trial; it is not approved for sale in the United States.
  ViaLase is a medical device manufacturer rather than a software vendor: it publishes no public API, developer portal, SDK,
  or machine-readable specification, and vialase.com is a WordPress marketing and clinical-education site.'
image: https://www.vialase.com/wp-content/uploads/2024/07/vialase-social-image.png
url: https://raw.githubusercontent.com/api-evangelist/vialase/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pass-no-api-surface
specificationVersion: '0.20'
created: '2026-09-02'
modified: '2026-09-02'
tags:
- Company
- Medical Devices
- Healthcare
- MedTech
- Ophthalmology
- Glaucoma
- Femtosecond Laser
- Surgical Devices
- Clinical Trials
- Medical Imaging
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.vialase.com/
- type: Blog
  url: https://www.vialase.com/news/
- type: BlogRSS
  url: https://www.vialase.com/feed/
- type: PrivacyPolicy
  url: https://www.vialase.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/vialase/
- type: DomainSecurity
  url: security/vialase-domain-security.yml
- type: LLMsTxt
  url: llms/vialase-llms.txt
x-enrichment:
  date: '2026-09-02'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: ViaLase manufactures a single clinical-stage ophthalmic capital device — the ViaLuxe femtosecond laser with its
    ViaLens patient interface and ViaVue gonio camera — whose only data connectivity is a Bluetooth-paired tablet at the bedside;
    vialase.com is an eleven-page WordPress marketing and clinical-education site with no api./developer./docs./status./portal./trust.
    hostname anywhere in DNS, and the only machine-readable JSON served on the domain is the stock WordPress core REST API
    at /wp-json/, which is CMS scaffolding rather than a product API.
  evidence:
  - url: https://www.vialase.com/openapi.json
    status: 404
  - url: https://www.vialase.com/graphql
    status: 404
  - url: https://www.vialase.com/llms.txt
    status: 404
  - url: https://www.vialase.com/.well-known/agent-card.json
    status: 404
  - url: https://www.vialase.com/.well-known/security.txt
    status: 404
  - url: https://www.vialase.com/.well-known/api-catalog
    status: 404
  - url: https://www.vialase.com/wp-json/
    status: 200
  - url: https://www.vialase.com/
    status: 200
  checked: '2026-09-02'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/vialase"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/vialase/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/vialase/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.